Strategic customers PeakData serves more than half of the top 20 pharmaceutical companies, indicating strong incumbent demand and potential for upsell within leading pharma players through expanded usage of their targeting and segmentation SaaS platform.

Global footprint With offices and staff across the USA, Germany, UK, Poland, Netherlands, and Switzerland, there are opportunities to tailor regional expansions, multilingual support, and country-specific integrations to accelerate sales cycles and customer success globally.

Product expansion Launch of Healthscape and AI-powered data mining capabilities signals a growing product moat; upsell opportunities exist around advanced analytics, MA workflow enhancements, and broader AI-assisted targeting for pharma commercial teams.

Financial runway Current funding of twelve million dollars and revenue in the low to mid-range of the SaaS pharma segment suggests a solid growth trajectory with potential for tiered pricing, larger multi-year commitments, and expanded use-cases to deepen enterprise value.

Tech stack fit Reliance on cloud and AI tools (AWS, Vertex AI, analytics, VPC) indicates alignment with modern data-driven pharma workflows; selling points can emphasize scalability, security, and compliance features to address procurement and IT due diligence.